Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosome therapy versus PRP for androgenic alopecia
IRCT20181005041243N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2025
- Countries
- 1
01
Overview
Phase 3, single-blind trial of platelet-rich plasma in androgenetic alopecia (AGA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Safety and efficacy of the treatments. Started Mar 2025; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20181005041243N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181005041243N5.